Back to Search
Start Over
Fungating and Ulcerating Breast Cancer: Wound Closure Algorithm, Complications, and Survival Trends.
- Source :
-
Indian journal of surgical oncology [Indian J Surg Oncol] 2023 Mar; Vol. 14 (1), pp. 93-105. Date of Electronic Publication: 2022 Aug 27. - Publication Year :
- 2023
-
Abstract
- Fungating breast cancer severely affects patients' daily lives, and patient management poses major oncology challenges. To present 10-year outcomes of unique tumor presentation, suggesting a focused algorithm for surgical management and providing deep analysis for factors affecting survival and surgical outcomes. Eighty-two patients with fungating breast cancer were enrolled in the period from January 2010 to February 2020 in the Mansoura University Oncology Center database. Epidemiological and pathological characteristics, risk factors, different surgical treatment techniques, and surgical and oncological outcomes were reviewed. Preoperative systemic therapy was used in 41 patients, with the majority (77.8%) showing progressive response. Mastectomy was performed in 81 (98.8%) patients, with primary wound closure in 71 (86.6%), and wide local excision in a single patient (1.2%). Different reconstructive techniques in non-primary closure operations were used. Complications were reported in 33 (40.7%) patients, of which 16 (48.5%) were of Clavien-Dindo grade II category. Loco-regional recurrence occurred in 20.7% of patients. The mortality rate during follow-up was 31.7% ( n = 26). Estimated mean overall survival (with 95% CI) was 55.96 (41.98-69.9) months; estimated mean loco-regional recurrence-free survival (with 95% CI) was 38.01 (24.6-51.4) months. Surgery is a cornerstone fungating breast cancer treatment option, but at the expense of high morbidity. Sophisticated reconstructive procedures may be indicated for wound closure. A suggested algorithm based on the center's experience of wound management in difficult mastectomy cases is displayed.<br />Competing Interests: Conflict of InterestThe authors declare no competing interests.<br /> (© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
Details
- Language :
- English
- ISSN :
- 0975-7651
- Volume :
- 14
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Indian journal of surgical oncology
- Publication Type :
- Academic Journal
- Accession number :
- 36891440
- Full Text :
- https://doi.org/10.1007/s13193-022-01602-x